FOLH1 and posterior cortical atrophy: Data from ORIOLE, a similar randomized Phase II study investigating the efficacy of SABR in forestalling metastases for hormone-sensitive PCa compared with observation, provide evidence for the value of PSMA PET/CT in controlling disease [52].